Structural characterization and mechanisms of macrophage immunomodulatory activity of a novel polysaccharide with a galactose backbone from the processed Polygonati Rhizoma.
J Pharm Anal
; 14(7): 100974, 2024 Jul.
Article
in En
| MEDLINE
| ID: mdl-39185336
ABSTRACT
A purified polysaccharide with a galactose backbone (SPR-1, Mw 3,622 Da) was isolated from processed Polygonati Rhizoma with black beans (PRWB) and characterized its chemical properties. The backbone of SPR-1 consisted of [(4)-ß-D-Galp-(1]9 â 4,6)-ß-D-Galp-(1 â 4)-α-D-GalpA-(1 â 4)-α-D-GalpA-(1 â 4)-α-D-Glcp-(1 â 4,6)-α-D-Glcp-(1 â 4)-α/ß-D-Glcp, with a branch chain of R1 ß-D-Galp-(1 â 3)-ß-D-Galp-(1â connected to the â4,6)-ß-D-Galp-(1â via O-6, and a branch chain of R2 α-D-Glcp-(1 â 6)-α-D-Glcp-(1â connected to the â4,6)-α-D-Glcp-(1â via O-6. Immunomodulatory assays showed that the SPR-1 significantly activated macrophages, and increased secretion of NO and cytokines (i.e., IL-1ß and TNF-α), as well as promoted the phagocytic activities of cells. Furthermore, isothermal titration calorimetry (ITC) analysis and molecular docking results indicated high-affinity binding between SPR-1 and MD2 with the equilibrium dissociation constant (K D) of 18.8 µM. It was suggested that SPR-1 activated the immune response through Toll-like receptor 4 (TLR4) signaling and downstream responses. Our research demonstrated that the SPR-1 has a promising candidate from PRWB for the TLR4 agonist to induce immune response, and also provided an easily accessible way that can be used for PR deep processing.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
J Pharm Anal
Year:
2024
Document type:
Article
Affiliation country:
Country of publication: